Endpoints News 生物医药· Elizabeth Cairns·· 2026-09-30AI 评分41
#EASD26:Zealand 与 Roche 的胰淀素类似物中剂量减重效果最佳,落后于 Lilly
#EASD26: Zealand and Roche's amylin works best at middle dose, trails Lilly's
AI 导读
在 EASD26 上公布的 Zealand Pharma 与 Roche 的胰淀素类似物 II 期肥胖试验中,中剂量组减重效果最佳,但仍落后于 Lilly 同类产品,结果被认为令人失望。
正文
MILAN — Weight loss with Zealand Pharma and Roche’s amylin analog was regarded as disappointing when its Phase 2 obesity trial reported
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news